Rubella vaccination during oral contraceptive care

Br Med J. 1977 Aug 20;2(6085):517. doi: 10.1136/bmj.2.6085.517.

Abstract

PIP: The recommendation of the British Department of Health and Social Security (DHSS) is that women regularly receiving family planning advice should be screened serologically and offered rubella vaccination if seronegative. M. Gringas et al. have shown that this practice can be carried out, but ignores the feature of "doctor compliance" in nonresearch facilites where large-scale screenings are not currently possible. Better results can be obtained by "blind" vaccination of all candidates for contraception to be offered at the expieration of a 3-month prescription of the pill. This "blind" vaccination poses the problem of a possible pregnant vaccinee. In this case, distinguishing the maternal rubella-specific IgM (product of recent vaccination) from rubella-specific IgG (from previous rubella infection) could determine the necessity of termination. Furthermore, rubella vaccine, if given to a seropositive woman, has not yet been exonerated from all possible risk. Under the present program, payment for vaccinating male staff working in antenatal clinics is withheld unless proved seronagative. Family planning clinics should have a rubella policy.

Publication types

  • Letter

MeSH terms

  • Contraceptives, Oral*
  • Female
  • Humans
  • Rubella Vaccine / administration & dosage*

Substances

  • Contraceptives, Oral
  • Rubella Vaccine